Practice Pearl
In patients requiring chronic nonsteroidal antiinflammatory drug therapy, PN 400 (enteric-coated naproxen with esomeprazole) effectively reduces the risk of developing gastric and duodenal ulcers compared with enteric-coated naproxen alone.